Home › Macular Edema
Macular Edema clinical trials recruiting in the U.S.
8 studies for Macular Edema are recruiting participants at sites across the United States.
Cities with the most studies
- Carmel, IN5 studies
- Hagerstown, MD5 studies
- San Antonio, TX5 studies
- Sacramento, CA4 studies
- The Woodlands, TX4 studies
- Raleigh, NC4 studies
- Austin, TX4 studies
- Phoenix, AZ4 studies
- Houston, TX3 studies
- Hartford, CT3 studies
- Plano, TX3 studies
- Columbia, SC3 studies
- Glendale, CA3 studies
- Denver, CO3 studies
- Boston, MA3 studies
- Nashville, TN3 studies
- Charleston, SC3 studies
- St. Petersburg, FL3 studies
- New London, CT3 studies
- Cypress, TX3 studies
- Orlando, FL3 studies
- Cleveland, OH3 studies
- Pasadena, CA3 studies
- Bakersfield, CA3 studies
- Fort Lauderdale, FL3 studies
- Eugene, OR3 studies
By state
- Arizona5 studies
- California5 studies
- Colorado4 studies
- Connecticut5 studies
- Florida5 studies
- Indiana5 studies
- Maryland5 studies
- Massachusetts4 studies
- New Jersey3 studies
- New York4 studies
- North Carolina7 studies
- Ohio4 studies
- Oregon3 studies
- Pennsylvania3 studies
- South Carolina5 studies
- Tennessee4 studies
- Texas5 studies
Recently updated studies
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07705607A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06962839Imaging Retinal Vasculature in Infant Eyes
RecruitingObservational study
2 Months · All sexes · Updated Oct 19, 2026 · NCT05558059Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 5, 2026 · NCT06395285A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06996080Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Nov 26, 2025 · NCT04225611From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.